IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

WeylChem Hunts for ‘Sizable’ Deals to Further Increase Sales

3:07 PM MST | February 18, 2008 | Alex Scott

Private equity-owned chemicals manufacturer WeylChem (Frankfurt) is seeking major acquisitions as part of a strategy to maintain strong double-digit sales growth, the company told CW at the Informex specialty and fine chemicals expo, held recently in New Orleans. WeylChem’s sales grew 70% in each of the past two years largely through acquisitions, to reach about €600 million ($873 million) in 2007. The company’s sales to the pharmaceuticals sector are about €250 million/year, making WeylChem a top-20 custom fine chemical player. Maintaining...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa